| 精准医疗与伴随诊断专刊 |
|
|
|
|
| 生物标记物与精准医疗研究进展 |
蒋析文( ),董子维,刘悦,朱小亚 |
| 中山大学达安基因股份有限公司 广州 510665 |
|
| Reserch Progress on Biomarkers and Precision Medicine |
| Xi-wen JIANG(),Zi-wei DONG,Yue LIU,Xiao-ya ZHU |
| Da An Gene Co.,Ltd. Of Sun yat-sen University, Guanzhou 510665, China |
引用本文:
蒋析文,董子维,刘悦,朱小亚. 生物标记物与精准医疗研究进展[J]. 中国生物工程杂志, 2019, 39(2): 74-81.
Xi-wen JIANG,Zi-wei DONG,Yue LIU,Xiao-ya ZHU. Reserch Progress on Biomarkers and Precision Medicine. China Biotechnology, 2019, 39(2): 74-81.
链接本文:
https://manu60.magtech.com.cn/biotech/CN/10.13523/j.cb.20190209
或
https://manu60.magtech.com.cn/biotech/CN/Y2019/V39/I2/74
|
| [1] |
Collins F S, Varmus H . A New Initiative on Precision Medicine. N Engl J Med, 2015,372(9):793-795.
doi: 10.1056/NEJMp1500523
pmid: 25635347
|
| [2] |
Liu X Y, Fan H Y , Sui-Yan Y E, et al. Combined traditional and modern method detection in the diagnosis of TB laboratory value. Journal of Yanan University(Medical Science Edition), 2016,14(4):27-30.
|
| [3] |
Ashley E A . The precision medicine initiative: A new national effort. JAMA, 2015,313(21):2119-2120.
doi: 10.1001/jama.2015.3595
|
| [4] |
Ptolemy A S, Rifai N . What is a biomarker? Research investments and lack of clinical integration necessitate a review of biomarker terminology and validation schema. Scandinavian Journal of Clinical and Laboratory Investigation, 2010,70(sup242):9.
doi: 10.3109/00365513.2010.493354
pmid: 20515269
|
| [5] |
Tan L M, Long T T, Guan X L , et al. Diagnostic value of vitamin D status and bone turnover markers in rheumatoid arthritis complicated by osteoporosis. Annals of Clinical & Laboratory Science, 2018,48(2):197-204.
pmid: 29678847
|
| [6] |
Rykova E Y, Morozkin E S, Ponomaryova A A , et al. Cell-free and cell-bound circulating nucleic acid complexes: mechanisms of generation, concentration and content. Expert Opinion on Biological Therapy, 2012,12(S1):S141-S153.
doi: 10.1517/14712598.2012.673577
pmid: 22500614
|
| [7] |
Dawson S J, Rosenfeld N, Caldas C , et al. Circulating tumor DNA to monitor metastatic breast cancer. New England Journal of Medicine, 2013,368(13):1199-1209.
doi: 10.1056/NEJMoa1213261
pmid: 23822788
|
| [8] |
Wan Jonathan C M, Massie C, Javier G C , et al. Liquid biopsies come of age: towards implementation of circulating tumour DNA. Nature Reviews Cancer, 2017,17(4):223.
doi: 10.1038/nrc.2017.7
pmid: 28233803
|
| [9] |
Plaks V, Koopman C D , Werb Z. Circulating Tumor Cells. Science, 2013,341(6151):1186-1188.
doi: 10.1126/science.1235226
|
| [10] |
Uyen-Thao L, Peter B, Francesco P , et al. Intraoperative detection of circulating tumor cells in pulmonary venous blood during metastasectomy for colorectal lung metastases. Scientific Reports, 2018,8(1):8751.
doi: 10.1038/s41598-018-26410-8
pmid: 29884810
|
| [11] |
Tong B, Xu Y, Zhao J , et al. Prognostic significance of circulating tumor cells in non-small cell lung cancer patients undergoing chemotherapy. Oncotarget, 2017,8(49):86615-86624.
doi: 10.18632/oncotarget.21255
pmid: 5689711
|
| [12] |
Yu M, Bardia A, Aceto N , et al. Cancer therapy. Ex vivo culture of circulating breast tumor cells for individualized testing of drug susceptibility. Science, 2014,345(6193).
doi: 10.1126/science.1253533
pmid: 25013076
|
| [13] |
Pan B T, Johnstone R M . Fate of the transferrin receptor during maturation of sheep reticulocytes in vitro: selective externalization of the receptor. Cell, 1983,33(3):967-978.
doi: 10.1016/0092-8674(83)90040-5
pmid: 6307529
|
| [14] |
Johnstone R M . Revisiting the road to the discovery of exosomes. Blood Cells Molecules & Diseases, 2005,34(3):214-219.
doi: 10.1016/j.bcmd.2005.03.002
pmid: 15885604
|
| [15] |
Pan B T, Teng K, Wu C , et al. Electron microscopic evidence for externalization of the transferrin receptor in vesicular form in sheep reticulocytes. Journal of Cell Biology, 1985,101(3):942-948.
doi: 10.1083/jcb.101.3.942
pmid: 2113705
|
| [16] |
Johnstone R M . Exosomes biological significance: A concise review. Blood Cells, Molecules, and Diseases, 2006,36(2):315-321.
|
| [17] |
Gang C, Huang A C, Wei Z , et al. Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response. Nature, 2018,560:382-386.
doi: 10.1038/s41586-018-0392-8
|
| [18] |
Haderk F, Schulz R, Iskar M , et al. Tumor-derived exosomes modulate PD-L1 expression in monocytes. Sci Immunol, 2017, 2(13):eaah5509.
|
| [19] |
Kirschfink M, Terness P . Immunoblotting. Methods Mol Med, 1997,13(6):361-371.
|
| [20] |
Engvall E . Enzyme immunoassay ELISA and EMIT. Methods Enzymol, 1980,70(A):419-439.
doi: 10.1016/S0076-6879(80)70067-8
|
| [21] |
Famulok M . Oligonucleotide aptamers that recognize small molecules. Curr Opin Struct Biol, 1999,9(3):324-329.
doi: 10.1016/S0959-440X(99)80043-8
|
| [22] |
Kwok P Y . SNP genotyping with fluorescence polarization detection. Human Mutation, 2002,19(4):315-323.
doi: 10.1002/humu.10058
pmid: 11933186
|
| [23] |
Ronaghi M . Pyrosequencing sheds light on DNA sequencing. Genome Research, 2001,11(1):3-11.
doi: 10.1101/gr.11.1.3
pmid: 11156611
|
| [24] |
Ferguson J A, Steemers F J, Walt D R . High-density fiber-optic DNA random microsphere array. Analytical Chemistry, 2000,72(22):5618-5624.
doi: 10.1021/ac0008284
pmid: 11101240
|
| [25] |
Hindson C M, Chevillet J R, Briggs H A , et al. Absolute quantification by droplet digital PCR versus analog real-time PCR. Nature Methods, 2013,10(10):1003.
doi: 10.1038/nmeth.2633
pmid: 23995387
|
| [26] |
Butler E K, Gersch J, Mcnamara A , et al. HBV serum DNA and RNA levels in nucleos(t)ide analogue‐treated or untreated patients during chronic and acute infection. Hepatology, 2018,68(6):2106-2117.
doi: 10.1002/hep.30082
pmid: 29734472
|
| [27] |
Halgand B, Desterke C , Rivière, Lise, et al. Hepatitis B virus pregenomic RNA in hepatocellular carcinoma: A nosological and prognostic determinant. Hepatology, 2017,67(1):86-96.
doi: 10.1002/hep.29463
pmid: 28802063
|
| [28] |
DNAArbyn M, Paraskevaidis E, Martin-Hirsch P , et al. Clinical utility of HPV-DNA detection: Triage of minor cervical lesions, follow-up of women treated for high-grade CIN: An update of pooled evidence. Gynecologic Oncology, 2005,99(3 suppl):S7-S11.
doi: 10.1016/j.ygyno.2005.07.033
pmid: 16154623
|
| [29] |
Liao M Y, Huang Y . Analysis of vaginoscopy and HPV-DNA detection results of patients diagnosed with cervical atypical squamous cells. Maternal & Child Health Care of China, 2011,26(15):2274-2276.
|
| [30] |
Wentzensen N, Vinokurova S , Magnus V K D. Systematic review of genomic integration sites of human papillomavirus genomes in epithelial dysplasia and invasive cancer of the female lower genital tract. Cancer Research, 2004,64(11):3878-3884.
doi: 10.1158/0008-5472.CAN-04-0009
|
| [31] |
Ren C, Zhu Y, Yang L , et al. Diagnostic performance of HPV E6/E7 mRNA assay for detection of cervical high-grade intraepithelial neoplasia and cancer among women with ASCUS Papanicolaou smears. Archives of Gynecology & Obstetrics, 2018,297(2):425-432.
doi: 10.1007/s00404-017-4588-1
pmid: 29143102
|
| [32] |
Mok T S, Wu Y L, Thongprasert S , et al. Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma. The Journal of Evidence-Based Medicine, 2009,361(10):947.
|
| [33] |
Tey S K, Bollard C M, Heslop H E . Adoptive T-cell transfer in cancer immunotherapy. Immunology and Cell Biology, 2006,84(3):281-289.
doi: 10.1111/j.1440-1711.2006.01441.x
pmid: 16681825
|
| [34] |
Ramos C A, Heslop H E, Brenner M K . CAR-T cell therapy for lymphoma. Annual Review of Medicine, 2016,67(1):165.
doi: 10.1146/annurev-med-051914-021702
pmid: 4732525
|
| [35] |
Gross G, Waks T, Eshhar Z . Expression of immunoglobulin-T-cell receptor chimeric molecules as functional receptors with antibody-type specificity. Proc Natl Acad Sci USA, 1989,86(24):10024-10028.
doi: 10.1073/pnas.86.24.10024
|
| [36] |
Eshhar Z, Waks T, Gross G , et al. Specific activation and targeting of cytotoxic lymphocytes through chimeric single chains consisting of antibody-binding domains and the gamma or zeta subunits of the immunoglobulin and T-cell receptors. Proceedings of the National Academy of Sciences of the United States of America, 1993,90(2):720-724.
doi: 10.1073/pnas.90.2.720
|
| [37] |
Brocker T . Chimeric Fv-ζ or Fv-ε receptors are not sufficient to induce activation or cytokine production in peripheral T cells. Blood, 2000,96(5):1999-2001.
doi: 10.1097/01.NNR.0000280661.34502.c1
pmid: 10961908
|
| [38] |
Finney H M, Lawson A D, Bebbington C R , et al. Chimeric receptors providing both primary and costimulatory signaling in T cells from a single gene product. Journal of Immunology, 1998,161(6):2791-2797.
pmid: 9743337
|
| [39] |
Gianpietro D, Barbara S, Malcolm B . Fifteen years of gene therapy based on chimeric antigen receptors: “Are we nearly there yet? ” Human Gene Therapy, 2009,20(11):1229-1239.
doi: 10.1089/hum.2009.142
pmid: 19702437
|
| [40] |
Marin V, Pizzitola I, Agostoni V , et al. Cytokine-induced killer cells for cell therapy of acute myeloid leukemia: improvement of their immune activity by expression of CD33-specific chimeric receptors. Haematologica, 2010,95(12):2144.
doi: 10.3324/haematol.2010.026310
pmid: 20713459
|
| [41] |
Chmielewski M, Abken H . TRUCKs: the fourth generation of CARs. Expert Opinion on Biological Therapy, 2015,15(8):1145.
doi: 10.1517/14712598.2015.1046430
pmid: 25985798
|
| [42] |
Lim W A , June C H. the principles of engineering immune cells to treat cancer. Cell, 2017,168(4):724.
doi: 10.1016/j.cell.2017.01.016
pmid: 28187291
|
| [43] |
Zamai L, Zotto G D, Buccella F , et al. Cytotoxic functions and susceptibility to apoptosis of human CD56bright NK cells differentiated in vitro from CD34 + hematopoietic progenitors . Cytometry Part A, 2012,81A(4):294-302.
doi: 10.1002/cyto.a.22025
pmid: 22319021
|
| [44] |
Frey M, Packianathan N B, Fehniger T A , et al. Differential expression and function of L-selectin on CD56bright and CD56dim natural killer cell subsets. Journal of Immunology, 1998,161(1):400-408.
pmid: 9647249
|
| [45] |
Tang X, Yang L, Li Z , et al. First-in-man clinical trial of CAR NK-92 cells: safety test of CD33-CAR NK-92 cells in patients with relapsed and refractory acute myeloid leukemia. American Journal of Cancer Research, 2018,8(6):1083.
pmid: 30034945
|
| [46] |
Oates J, Jakobsen B K . ImmTACs. OncoImmunology, 2013,2(2):e22891.
doi: 10.4161/onci.22891
|
| [47] |
Sharma P, Allison J P . The future of immune checkpoint therapy. Science, 2015,348(6230):56.
doi: 10.1126/science.aaa8172
|
| [48] |
Jin X, Mu P . Targeting breast cancer metastasis. Breast Cancer: Basic and Clinical Research, 2015: 23.
|
| [49] |
Le D T, Durham J N, Smith K N , et al. Mismatch-repair deficiency predicts response of solid tumors to PD-1 blockade. Science, 2017,357(6349):409.
doi: 10.1126/science.aan6733
pmid: 5576142
|
| [50] |
Gandara D R, Paul S M, Marcin K , et al. Blood-based tumor mutational burden as a predictor of clinical benefit in non-small-cell lung cancer patients treated with atezolizumab. Nature Medicine, 2018.
doi: 10.1038/s41591-018-0134-3
|
| [51] |
Zachary R C, Caitlin F C, David F , et al. Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden. Genome Medicine, 2017,9:34.
doi: 10.1186/s13073-017-0424-2
pmid: 5395719
|
| [52] |
Biswas A . Human papillomavirus (HPV) and cervical cancer. Journal of the Indian Medical Association, 2000,98(2):53-55.
doi: 10.2217/14750708.5.3.273
pmid: 11016151
|
| [53] |
Kyrgiou M, Shafi M I . HPV vaccine. Obstetrics Gynaecology & Reproductive Medicine, 2009,19(1):26-28.
|
| [54] |
Plosker G L. Sipuleucel-T . Drugs, 2011,71(1):101-108.
doi: 10.2165/11206840-000000000-00000
|
| [55] |
Patrick A O, Hu Z T, Keskin D B , et al. An immunogenic personal neoantigen vaccine for patients with melanoma. Nature, 2017,547(7662):217-221.
doi: 10.1038/nature22991
|
| [56] |
Sahin U, Derhovanessian E, Miller M , et al. Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer. Nature, 2017,547(7662):222-226.
doi: 10.1038/nature23003
|
| [57] |
Sagiv-Barfi I, Czerwinski D K, Levy S , et al. Eradication of spontaneous malignancy by local immunotherapy. Science Translational Medicine, 2018, 10(426):eaan4488.
doi: 10.1126/scitranslmed.aan4488
pmid: 29386357
|
| [58] |
Andrieu G P, Denis G V . BET proteins exhibit transcriptional and functional opposition in the epithelial-to-mesenchymal transition. Molecular Cancer Research, 2018,16(4):580-586.
doi: 10.1158/1541-7786.MCR-17-0568
|
| [59] |
Mcnair C, Xu K, Mandigo A C , et al. Differential impact of RB status on E2F1 reprogramming in human cancer. Journal of Clinical Investigation, 2018,128(1):341.
doi: 10.1172/JCI93566
pmid: 29202480
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
| |
Shared |
|
|
|
|
| |
Discussed |
|
|
|
|
